Company intelligence / Profile preview
Seed Health
Venice Beach/Los Angeles/Venice*, California, United Statesseedhealth.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Clinical
01
Overview
Seed Health has developed a portfolio of clinically validated probiotic/synbiotic products such as DS‑01® Daily Synbiotic (for adults), PDS‑08® Pediatric Daily Synbiotic (for children), and VS‑01™ Vaginal Synbiotic. These have been tested in multiple double-blind randomized controlled trials showing efficacy in restoring optimal microbiomes in the gut or vagina. The company also collaborates on live biotherapeutic drug development targeting unmet needs in urogenital/reproductive health through LUCA Biologics. Their environmental arm develops microbial solutions to ecological challenges like honeybee preservation and coral reef regeneration. Revenue was estimated at $200M in FY2024 with rapid growth expected due to new product launches and retail expansion into Target stores nationwide.
- Therapeutic areas
- GastroenterologyDermatologyMetabolic DisordersWomen's Health
- Modalities
- ProbioticsPrebioticsSynbioticsPostbioticsLive biotherapeutics
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Academic partnerships with Weizmann Institute of Science, University of Zurich/SIAF, University of Maryland School of MedicineFullscript distribution partnershipretail partnership with Target stores nationwide
Beyond the preview
Go deeper on Seed Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Seed Health.